Breast cancer: from Halsted to Harney
The management of breast cancer has evolved in the last 40 years to now encompass not only treating the cancer in the most effective way, but also to detect and treat cancers before they can pose a risk to patients. This evolution in therapy and diagnostics has moved away from treating patients with the maximum amount of therapy they can tolerate towards a new paradigm where patents receive the minimum treatment to be most efficacious.
KeywordsBreast Cancer Surgery Risk Screening
Conflict of interest
No conflict of interest in relation to this paper.
- 18.Smith RA, Duffy SW, Tabár L (2012) Breast cancer screening: the evolving evidence. Oncology (Williston Park) 26(5):471–475, 479–81, 485–6Google Scholar